Mar 02, 2026, 07:01 ETHealth Canada Approves Ozempic® (semaglutide injection) to Reduce the Risk of Major Adverse...
Ozempic® is indicated as an adjunct to diet, exercise, and standard of care to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or...